ANGLE is a world-leading liquid biopsy company. Their Parsortix® technology enables the capture and harvest of viable circulating tumor cells (CTCs) from patient blood.

Medical Devices

ANGLE

Andrew Newland

Karen Miller

Ian Griffiths

Michelle Munson

Dr. Alexandre Izmailov

Brett Swansiger

Ashok Venkitaraman

James Reuben

Jan Groen

Brian Howlett

Clive Stanway

Joseph Khoury

Adrian Newland

Harold Swerdlow

Greg Shaw

Daniel Danila

Juliet Thompson

The Scientific Research and Development team at ANGLE spearheads the advancement of liquid biopsy technologies, focusing on the innovation and enhancement of Parsortix® for capturing circulating tumor cells. This multidisciplinary team, comprised of scientists and clinical laboratory experts, conducts research, develops assays, and ensures high-quality manufacturing processes to drive breakthroughs in cancer diagnostics and improve patient outcomes. Their collaborative efforts support both product development and clinical applications, contributing to ANGLE's position as a leader in the field.

Scientific Research and Development

The Operations and Commercial Management team at ANGLE is responsible for driving the strategic implementation of the company's commercial initiatives and ensuring operational excellence. This team collaborates to optimize business processes, oversee product management, and enhance sales strategies across regions, ultimately supporting the growth and accessibility of the Parsortix® technology in the liquid biopsy market.

Operations and Commercial Management

The Research and Development team at ANGLE is dedicated to advancing the Parsortix® technology by conducting cutting-edge clinical studies and validating product efficacy. They collaborate closely with medical professionals to ensure the capture and analysis of viable circulating tumor cells is effective, while also focusing on innovative microfluidics design to enhance product performance. Their efforts drive the development of new applications and reinforce ANGLE's leadership in liquid biopsy solutions.

Research and Development

The Financial and Accounting Team at ANGLE is responsible for managing the company’s financial health and ensuring compliance with accounting regulations. They oversee budgeting, financial reporting, and the accurate recording of transactions, while also providing strategic financial analysis to support business growth. This team plays a critical role in maintaining financial stability and fostering transparency across the organization.

Financial and Accounting Team

The Leadership Team at ANGLE drives the strategic direction and overall vision of the company, focusing on advancing the innovative Parsortix® technology. Comprising top executives, this team collaborates on financial planning, operational excellence, and fostering relationships within the healthcare sector to enhance the impact of liquid biopsy solutions in patient care.

Leadership Team

The Engineering and Technical Operations team at ANGLE is responsible for ensuring the reliability and efficiency of the Parsortix® technology through robust product support and technical expertise. They manage the development and manufacturing processes, troubleshoot operational issues, and provide technical guidance to enhance product performance, ensuring seamless integration in clinical applications for liquid biopsies.

��

ANGLE

Org chart

Board & advisors

Teams

Scientific Research and Development

Operations and Commercial Management

Research and Development

Financial and Accounting Team

Leadership Team

Engineering and Technical Operations

Offices

��������

ANGLE

Org chart

Board & advisors

Teams

Scientific Research and Development

Operations and Commercial Management

Research and Development

Financial and Accounting Team

Leadership Team

Engineering and Technical Operations

Offices

Related companies

��